Cargando…

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome

OBJECTIVE: Currently, management of acute respiratory distress syndrome (ARDS) in COVID-19 infection with invasive mechanical ventilation results in poor prognosis and high mortality rates. Interventions to reduce ventilatory requirements or preclude their needs should be evaluated in order to impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toma, Andrew, Darwish, Christina, Taylor, Michele, Harlacher, Justin, Darwish, Ribal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074548/ https://www.ncbi.nlm.nih.gov/pubmed/33986957 http://dx.doi.org/10.1155/2021/8881115

Ejemplares similares

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
por: Holliday, Zachary M., et al.
Publicado: (2021)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
por: Okur, H.K., et al.
Publicado: (2020)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
por: den Hollander, Bibiche, et al.
Publicado: (2022)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
por: Desilles, J. P., et al.
Publicado: (2020)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Claudius, Casper, et al.
Publicado: (2015)

USE OF ALTEPLASE AND DORNASE FOR LYSIS OF COVID-19-RELATED LOCULATED PLEURAL EFFUSION
por: STAIANO, PETER P, et al.
Publicado: (2022)

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
por: Jiang, Chuan, et al.
Publicado: (2020)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
por: Pottecher, Julien, et al.
Publicado: (2020)

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
por: Ramanathan, R, et al.
Publicado: (2013)

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015)

The adult respiratory distress syndrome.
por: Biondi, J. W., et al.
Publicado: (1986)

In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
por: Ricci, Francesca, et al.
Publicado: (2017)

Physiologic Improvement in Respiratory Acidosis Using Extracorporeal Co(2) Removal With Hemolung Respiratory Assist System in the Management of Severe Respiratory Failure From Coronavirus Disease 2019
por: Akkanti, Bindu, et al.
Publicado: (2021)

Guidelines on the management of acute respiratory distress syndrome
por: Griffiths, Mark J D, et al.
Publicado: (2019)

Management of Respiratory Distress Syndrome due to COVID-19 infection
por: Navas-Blanco, Jose R., et al.
Publicado: (2020)

The Acute Respiratory Distress Syndrome: Diagnosis and Management
por: Chiumello, Davide, et al.
Publicado: (2018)

Diagnosis and management of acute respiratory distress syndrome
por: Fernando, Shannon M., et al.
Publicado: (2021)

Management of paediatric acute respiratory distress syndrome
por: Schneider, N., et al.
Publicado: (2022)

Management of Patients with Acute Respiratory Distress Syndrome
por: Phillips, JoAnne K.
Publicado: (1999)

An Uncommon Cause of Adult Respiratory Distress Syndrome
por: Case, Theresa, et al.
Publicado: (2014)

Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome
por: Donato, Manuel, et al.
Publicado: (2021)

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
por: Sánchez Luna, Manuel, et al.
Publicado: (2020)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial
por: Livingston, Michael H., et al.
Publicado: (2017)

Pattern of anticoagulation prescription for patients with Covid-19 acute respiratory distress syndrome admitted to ICU. Does it impact outcome?
por: Nadeem, Rashid, et al.
Publicado: (2021)

What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?
por: Brown, Samuel M., et al.
Publicado: (2021)

Acute respiratory distress syndrome: epidemiology and management approaches
por: Walkey, Allan J, et al.
Publicado: (2012)

Usefulness of ultrasound in the management of acute respiratory distress syndrome
por: Chaari, Anis, et al.
Publicado: (2019)

Formal guidelines: management of acute respiratory distress syndrome
por: Papazian, Laurent, et al.
Publicado: (2019)

Paediatrics: how to manage acute respiratory distress syndrome
por: Hon, Kam Lun, et al.
Publicado: (2021)

Effect of albumin with furosemide in adult respiratory distress syndrome
por: Kuper, M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_jj0re1pcvphnv0ngthisri7brv